IDEXX Laboratories, Inc. provided earnings guidance for the full year 2022. For the period, the company expects Revenue to be in the range of $3,325 million to $3,365 million. EPS to be in the range of $7.74 to $7.98.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
509.8 USD | +1.80% | +6.08% | -8.15% |
May. 02 | BNP Paribas Adjusts Price Target on IDEXX Laboratories to $641 From $653 | MT |
May. 02 | Goldman Sachs Adjusts Price Target on IDEXX Laboratories to $600 From $675 | MT |
EPS Revisions
- Stock Market
- Equities
- IDXX Stock
- News IDEXX Laboratories, Inc.
- IDEXX Laboratories, Inc. Provides Earnings Guidance for the Full Year 2022